Navigation Links
Sanofi Enters Into Research Collaboration with Weill Cornell Medical College to Discover New Treatments for Tuberculosis
Date:6/29/2011

PARIS, June 29, 2011 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it entered into a research collaboration with Weill Cornell Medical College to develop new anti-infectives that aim to shorten the course of treatment of tuberculosis (TB) and provide effective therapies against drug-susceptible and drug-resistant strains of TB.

(Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO)

Under the terms of the collaboration, Sanofi will provide 80,000 chemical compounds to Dr. Carl Nathan's laboratory at Weill Cornell, where the compounds will be screened to assess their ability to inhibit growth of Mycobacterium tuberculosis. Weill Cornell has secured funding for the screening activities conducted by Dr. Nathan's team from the Bill & Melinda Gates Foundation. Sanofi and Weill Cornell will jointly determine if any compounds screened through the collaboration should be brought forward for optimization and further development.

"Since discovering rifampicin in the early 1960s, Sanofi has continued to pursue new therapeutic approaches to combat TB, including new vaccines and drug candidates with new mechanisms of action," said Elias Zerhouni, President, Global R&D at Sanofi. "This research collaboration with Weill Cornell will enable us to explore the potential of our existing compound library and pool the extensive knowledge of Dr. Nathan and his colleagues with Sanofi's drug development expertise to benefit TB patients worldwide in continuation of our long standing commitment to global health."

Every year, more than 1.7 million people worldwide die from TB. Today's TB drugs are more than 40 years old and must be taken for six to nine months for drug-sensitive disease and up to 24 months for drug-resistant disease. Long, demanding treatment schedules prove too much for many patients and the resulting
'/>"/>

SOURCE Sanofi
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Pasteur Commends Winners of International BioGENEius Challenge
2. Sanofi Announces Positive Results from the "All to Target" Study Evaluating Two Lantus® and Apidra® Regimens Versus Premixed Regimen
3. Medco, United BioSource and Sanofi Signed Global Agreement to Improve Quality of Patient Care Through Real-World Evidence
4. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
5. Sanofi Pasteur Donates Tdap Vaccine to Aid Storm Victims
6. sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
7. Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants
8. Sanofi-aventis Enters into Collaboration Agreement with Stanford University Bio-X to Focus on Early-Stage Scientific Research
9. Sanofi-Aventis Completes Acquisition of Genzyme Corporation
10. Sanofi-aventis Successfully Completes Exchange Offer for Genzyme Corporation
11. Navinta LLC is Pleased to Announce US FDA Approval of Sodium Ferric Gluconate Injection in Sucrose [a generic equivalent of Ferrlecit® Injection by Sanofi Aventis] Based on Its Proprietary Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 /PRNewswire-USNewswire/ ... that allows Kessler Foundation and New Jersey Health ... research, education and patient care programs has been ... chief executive officer of Kessler Foundation and ... Health Foundation. "The experience of New ...
(Date:9/30/2014)... 2014  Georgia-Pacific Professional is a leading provider ... a wide range of away from home applications. ... in healthcare, including hospitals, long-term care facilities, surgical ... its healthcare products and solutions to the dental ... of infection control in the dental office," said ...
(Date:9/30/2014)... -- In a recent study it was ... the Eldor spinal needle 25G, 103 mm appeared significantly ... spinal needles of the same gauge and length of ... an excellent type of regional anesthesia for many operations ... It is estimated that 100 million patients worldwide ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 2Georgia-Pacific Professional Brings Its Success in Medical Solutions to the Dental Community 3
... SAN DIEGO, Sept. 26, 2011 Elevation Pharmaceuticals, Inc., ... aerosol therapies for patients with respiratory diseases, today announced ... and Chief Business Officer and Pravin Soni, PhD, as ... created positions. The company also announced that it drew ...
... 26, 2011 Clermont Pharmaceuticals, Inc., a ... positive results from a phase III trial ... latanoprost was compared to Xalatan® (latanoprost ophthalmic ... glaucoma.  Non-preserved latanoprost achieved the primary efficacy ...
Cached Medicine Technology:Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 2Elevation Pharmaceuticals Strengthens Management Team with Appointment of Executives 3Clermont Pharmaceuticals Reports Positive Phase III Results for Drug to Treat Glaucoma 2
(Date:9/30/2014)... September 30, 2014 Coast Dental ... opening of its newest practice, located at 1010 Shaw ... x-rays, general dentistry services , and specialty dental ... addition to providing affordable and convenient dental care, our ... dental appointments . Call Coast Dental at 559-777-6113 to ...
(Date:9/30/2014)... September 30, 2014 In its latest blog ... and believes that having family close by during a stay ... not the process is successful, is focusing on 5 reasons ... lasting recovery. , “Achieving sobriety is not a one-time event, ... Drug Rehabilitation’s CEO Per Wickstrom . “It’s an ongoing ...
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... Rochelle, NY, September 30, 2014Levothyroxine (L-T4), long the ... in most patients, but some individuals do not ... about thyroid physiology may help to explain these ... Thyroid Association on thyroid hormone replacement reviewed the ... treatments to determine whether a change to the ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 OZ Naturals ... selling beauty brand on Amazon.com. , “The majority of ... respective beauty categories on Amazon.com,” said Craig Romero, CEO of ... UK on Amazon.co.uk and Canada on Amazon.ca , Romero went ... just launched earlier last month, are already taking over top ...
Breaking Medicine News(10 mins):Health News:Coast Dental Clovis Celebrates Grand Opening 2Health News:Coast Dental Clovis Celebrates Grand Opening 3Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 2Health News:New Best Drug Rehabilitation Blog Post Focuses on 5 Reasons Why Relapse Shouldn’t Stand in the Way of Recovery 3Health News:How to predict who will suffer the most from stress 2Health News:New hypothyroidism treatment guidelines from American Thyroid Association 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3
... More than nine million people, or 34 percent of ... drug benefit through Medicare Advantage plans with prescription drug ... Using just released data from the Center for ... database, Avalere researchers analyzed 2009 Medicare Part D open ...
... ST. LOUIS, Feb. 24 The deepening economic ... some would say failing -- health care,system at ... number of,uninsured and underinsured is rising. Also, faced ... those with insurance are not compliant in,taking critical ...
... and states reconsider funding for abstinence-only programs, the largest ... classes reveals that abstinence programs are plagued with factual ... and actively discourage the use of condoms to protect ... Texas Freedom Network Education Fund - Just Say ...
... women, but different genes might raise risk in black women ... a genetic marker that may indicate if a woman has ... says. , Shorter, white women who test positive for the ... to develop the muscular tumors in their uterus, according to ...
... study published in the February 2009 issue of the ... a highly reliable depression screening tool known as the ... and Europe can be effectively administered in resource poor ... needs have been underserved. The work also confirms that ...
... U.S. editors and producers traveled to Uganda last year ... fascinating countries. A highlight of the International Reporting Project ... and HIV/AIDS with Ugandan President Yoweri Museveni. At the ... three of the Gatekeepers will discuss the U.S. media,s ...
Cached Medicine News:Health News:1 in 3 Medicare Part D Enrollees Select Medicare Advantage Drug Plans for 2009 2Health News:Health and Wellness Programs in a Tight Economy: Why They Are Critical and How to Make Them Effective 2Health News:New Texas Study Reveals Serious Flaws in Abstinence Programs 2Health News:Inexpensive depression screening tool works in resource poor countries 2Health News:U.S. Media Report From Uganda: Wilson Center Panel Discusses Health, Environment, and Security in Africa 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... wide variety of applications. • Whole pipette is ... freely rotated against the handle to work in ... angle towards the microtiter plate. • The special ... common pipette tips, and provides a firm, parallel ...
Pipetman 8X200 Multichannel Pipette is an eight-channel, fully adjustable, air-displacement pipette having a useful volume range from 20 L to 200 L. Robustwith the usual Gilson qualities this pipette...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
Medicine Products: